Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders

J Neuroimmunol. 2016 Apr 15:293:100-104. doi: 10.1016/j.jneuroim.2016.03.004. Epub 2016 Mar 4.

Abstract

The interleukin 12 (IL-12) family plays important roles in autoimmune diseases. To explore the roles of the IL-12 family members IL-27 and IL-35 in the pathogenesis of neuromyelitis optica spectrum disorders (NMOSD), we determined their serum and cerebral spinal fluid levels and assessed potential correlations with clinical characteristics. Serum IL-27 levels were negatively correlated with disease severity and spinal cord lesion length, while serum IL-35 levels were negatively correlated with disease severity and annual relapse rate. Thus, IL-27 and IL-35 may be important biomarkers of NMOSD severity and these molecules might represent potential therapeutic cytokines for treating NMOSD.

Keywords: IL-12; IL-27; IL-35; Neuromyelitis optica spectrum disorders (NMOSD).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aquaporin 4 / immunology
  • Autoantibodies / blood
  • Disability Evaluation
  • Female
  • Humans
  • Interleukin-27 / blood*
  • Interleukins / blood*
  • Male
  • Neuromyelitis Optica / blood*
  • Neuromyelitis Optica / diagnosis
  • Neuromyelitis Optica / physiopathology
  • Retrospective Studies
  • Severity of Illness Index
  • Statistics as Topic
  • Statistics, Nonparametric

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Autoantibodies
  • Interleukin-27
  • Interleukins
  • interleukin-35, human